Information Provided By:
Fly News Breaks for August 12, 2015
ABMD
Aug 12, 2015 | 07:17 EDT
Stephens raised its price target on Abiomed to $128 from $103 as it believes management articulated a credible and arguably conservative case at its investor day for the company to keep growing organic revenue at a CAGR of more than 30% over the next 5 years. The firm maintains its Overweight rating on Abiomed shares.
News For ABMD From the Last 2 Days
There are no results for your query ABMD